Zimmer Biomet Holdings Inc (ZBH)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Zimmer Biomet Holdings Inc (ZBH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010873
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company with focus on musculoskeletal healthcare. It carries out the design, development, manufacture, and marketing of reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Its products and solutions are used for the treatment of patients suffering from disorders or injuries in bones, joints and supporting soft tissues. The company offers its products to orthopaedic surgeons, neurosurgeons, oral surgeons, other specialists, dentists and hospitals. The company sells its products through direct sales channels and distributors in Americas, Europe, Asia-Pacific, the Middle East and Africa. Zimmer Biomet is headquartered in Indiana, the US.

Zimmer Biomet Holdings Inc (ZBH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Zimmer Biomet Holdings Inc, Medical Devices Deals, 2011 to YTD 2017 10
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Zimmer Biotech Raises USD8.3 Million in Venture Financing 12
Private Equity 13
JANA Partners May Acquire Certain Stake in Zimmer Biomet 13
Partnerships 14
MiMedx Enters into Distribution Agreement with Zimmer 14
curasan Enters Into Distribution Agreement With Zimmer Dental 15
Licensing Agreements 16
BioCardia Enters into Licensing and Distribution Agreement with Biomet Biologics 16
Equity Offering 17
Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 17
Biomet Files Registration Statement For IPO To Raise Up To US$100 Million 19
Debt Offering 20
Zimmer Biomet Raises USD532 Million in Public Offering of 2.42% Notes Due 2026 20
Zimmer Biomet Raises USD532 Million in Public Offering of 1.4% Notes Due 2022 21
Acquisition 22
Zimmer Acquires Biomet for USD14 Billion 22
Zimmer Acquires Dornoch Medical Systems 24
CD Diagnostics Acquires 80% Stake In Citrano Medical Labs, Provider Of Clinical Laboratory Testing Services 25
Zimmer Biomet Holdings Inc – Key Competitors 26
Zimmer Biomet Holdings Inc – Key Employees 27
Zimmer Biomet Holdings Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 35
Financial Announcements 35
Nov 01, 2017: Zimmer Biomet Reports Third Quarter 2017 Financial Results 35
Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 36
Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 37
Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 38
Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 39
Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 40
Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 41
Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 42
Apr 28, 2016: Zimmer Biomet Holdings Reports First Quarter 2016 Financial Results 43
Corporate Communications 44
Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 44
Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 45
Legal and Regulatory 46
Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility 46
Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 47
Government and Public Interest 48
Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 48
Sep 22, 2016: Zimmer Biomet Contributes Additional $100,000 in Funding to the Orthopaedic Research and Education Foundation 49
Product News 50
Sep 08, 2016: Zimmer Biomet creates new jobs at Bridgend factory 50
Other Significant Developments 51
Oct 04, 2017: Zimmer Biomet Provides Update on Manufacturing Facilities in Guaynabo and Ponce, Puerto Rico 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Zimmer Biomet Holdings Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Zimmer Biomet Holdings Inc, Medical Devices Deals, 2011 to YTD 2017 10
Zimmer Biomet Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Zimmer Biotech Raises USD8.3 Million in Venture Financing 12
JANA Partners May Acquire Certain Stake in Zimmer Biomet 13
MiMedx Enters into Distribution Agreement with Zimmer 14
curasan Enters Into Distribution Agreement With Zimmer Dental 15
BioCardia Enters into Licensing and Distribution Agreement with Biomet Biologics 16
Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 17
Biomet Files Registration Statement For IPO To Raise Up To US$100 Million 19
Zimmer Biomet Raises USD532 Million in Public Offering of 2.42% Notes Due 2026 20
Zimmer Biomet Raises USD532 Million in Public Offering of 1.4% Notes Due 2022 21
Zimmer Acquires Biomet for USD14 Billion 22
Zimmer Acquires Dornoch Medical Systems 24
CD Diagnostics Acquires 80% Stake In Citrano Medical Labs, Provider Of Clinical Laboratory Testing Services 25
Zimmer Biomet Holdings Inc, Key Competitors 26
Zimmer Biomet Holdings Inc, Key Employees 27
Zimmer Biomet Holdings Inc, Other Locations 29
Zimmer Biomet Holdings Inc, Subsidiaries 30

★海外企業調査レポート[Zimmer Biomet Holdings Inc (ZBH)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Artizian Catering Services Limited:企業の戦略・SWOT・財務情報
    Artizian Catering Services Limited - Strategy, SWOT and Corporate Finance Report Summary Artizian Catering Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Latvenergo AS:電力:M&Aディール及び事業提携情報
    Summary Latvenergo AS (Latvenergo) is a state-owned power supply utility company that generates and supplies electricity and thermal energy, distributes electricity, leases transmission system assets. It generates electricity through various renewable energy sources such as hydropower, biomass, wind …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ingenico SA:戦略・SWOT・企業財務分析
    Ingenico SA - Strategy, SWOT and Corporate Finance Report Summary Ingenico SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock Holding Corp, is a biopharmaceutical company that discovers and develops novel medicines for serious unmet medical needs. Its proprietary technology platform develops new medicines, modulating supracellular activation, for the app …
  • Quality Systems Inc (QSII)-医療機器分野:企業M&A・提携分析
    Summary Quality Systems Inc (QSI) is a healthcare technology company that develops and markets practice management and electronic health records solutions. The company’s solutions comprise ambulatory solutions, population health management and analytics, RCM services, NextGen consulting services, in …
  • Navistar Defense, LLC:企業の戦略・SWOT・財務情報
    Navistar Defense, LLC - Strategy, SWOT and Corporate Finance Report Summary Navistar Defense, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alfa Group Consortium:企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Buzzi Unicem SpA:戦略・SWOT・企業財務分析
    Buzzi Unicem SpA - Strategy, SWOT and Corporate Finance Report Summary Buzzi Unicem SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Viking Line ABP:企業の戦略・SWOT・財務情報
    Viking Line ABP - Strategy, SWOT and Corporate Finance Report Summary Viking Line ABP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Empire District Electric Co:企業の戦略的SWOT分析
    The Empire District Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • SVOGL Oil Gas and Energy Ltd:企業の戦略的SWOT分析
    SVOGL Oil Gas and Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • DexTech Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary DexTech Medical AB (DexTech) is a research company that conducts research in the areas of urological oncology, mainly within prostate cancer. The company develops product candidates based on a modified carbon hydrate molecule combined with active substances such as generics. Its technology p …
  • Brain Resource Ltd (BRC):企業の財務・戦略的SWOT分析
    Summary Brain Resource Ltd (BRL) is a healthcare service provider that offers therapies. The company carries out research and development of brain products. Its products comprise iSPOT, Total Brain and MyBrainSolutions. BRL’s MyBrainSolutions is a brain health solution to know and train brain for pe …
  • Bank Hapoalim Private Banking:企業の戦略・SWOT・財務情報
    Bank Hapoalim Private Banking - Strategy, SWOT and Corporate Finance Report Summary Bank Hapoalim Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Bank of Ayudhya Public Co Ltd (BAY):企業の財務・戦略的SWOT分析
    Bank of Ayudhya Public Co Ltd (BAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Stryker Corporation (SYK)-医療機器分野:企業M&A・提携分析
    Summary Stryker Corporation (Stryker) is one of the leading manufacturers of medical equipment. It offers reconstructive, medical and surgical, and neurotechnology and spine products. Its major products include implants; surgical equipment and surgical navigation systems; endoscopic and communicatio …
  • Valero Energy Corporation:企業の戦略・SWOT・財務情報
    Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Valero Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • EnviroMission Limited (EVM)-エネルギー分野:企業M&A・提携分析
    Summary EnviroMission Limited (Enviro) is a renewable energy company that develops Solar Tower Technology (STT). It owns the license to STT across the world (excluding in China). The STT integrates the use of solar air collector and central updraft tower, to generate solar induced convective flow. I …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆